Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Hunt

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Medicine|August 19, 2016
Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvirZobair M Younossi, Maria Stepanova, Masao Omata, et al.
Medicine|July 19, 2016
Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimensZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
In an era of highly effective treatment, hepatitis C screening of the United States general population should be consideredZobair Younossi, Deidre Blissett, Rob Blissett, et al.
AACN Advanced Critical Care|May 1, 2010
Comparison of blood glucose management strategies to achieve control following cardiac surgery (computerized versus paper)Linda Halpin, Linda Henry, Elizabeth Dunning, et al.
Hepatology (Baltimore, Md.)|August 15, 2015
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLDZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 13, 2018
13C-Mixed Triglyceride Breath Test and Fecal Elastase as an Indirect Pancreatic Function Test in Cystic Fibrosis InfantsDorothea Stark Kent, Thomas Remer, Caron Blumenthal, et al.
BMJ Open Respiratory Research|May 9, 2023
Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and <i>Pseudomonas aeruginosa</i>Jagdev Singh, Dominic A Fitzgerald, Adam Jaffe, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2009
The use of spirometry testing prior to cardiac surgery may impact the Society of Thoracic Surgeons risk prediction score: a prospective study in a cohort of patients at high risk for chronic lung diseaseNiv Ad, Linda Henry, Linda Halpin, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trialZobair M Younossi, Maria Stepanova, Michael Charlton, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Medicine|August 19, 2016
Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvirZobair M Younossi, Maria Stepanova, Masao Omata, et al.
Medicine|July 19, 2016
Adherence to treatment of chronic hepatitis C: from interferon containing regimens to interferon and ribavirin free regimensZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
In an era of highly effective treatment, hepatitis C screening of the United States general population should be consideredZobair Younossi, Deidre Blissett, Rob Blissett, et al.
AACN Advanced Critical Care|May 1, 2010
Comparison of blood glucose management strategies to achieve control following cardiac surgery (computerized versus paper)Linda Halpin, Linda Henry, Elizabeth Dunning, et al.
Hepatology (Baltimore, Md.)|August 15, 2015
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009Zobair M Younossi, Munkhzul Otgonsuren, Linda Henry, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLDZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 13, 2018
13C-Mixed Triglyceride Breath Test and Fecal Elastase as an Indirect Pancreatic Function Test in Cystic Fibrosis InfantsDorothea Stark Kent, Thomas Remer, Caron Blumenthal, et al.
BMJ Open Respiratory Research|May 9, 2023
Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and <i>Pseudomonas aeruginosa</i>Jagdev Singh, Dominic A Fitzgerald, Adam Jaffe, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2009
The use of spirometry testing prior to cardiac surgery may impact the Society of Thoracic Surgeons risk prediction score: a prospective study in a cohort of patients at high risk for chronic lung diseaseNiv Ad, Linda Henry, Linda Halpin, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trialZobair M Younossi, Maria Stepanova, Michael Charlton, et al.
Pageof 8